THC and PTSD: Insights from a Dose-Finding Clinical Trial on Cognitive Reappraisal
A THC dose-finding clinical trial standardized in adults with PTSD revealed dose-dependent reductions in prefrontal brain activity during cognitive reappraisal. Despite these neural changes, self-reported emotional ratings remained unchanged. This…
In the Mix: 1 More Article — May 25, 2026
InMed Pharmaceuticals Q3 2025 earnings reveal continued financial losses impacting cannabinoid therapeutics development. This highlights challenges in pharmaceutical cannabinoid products. Clinicians should note the ongoing difficulties in drug…
7 on 7: The biggest stories from last week you might’ve missed
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
A 44-year study has found that long-term cannabis use does NOT accelerate cognitive … – Facebook
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
UK’s Care Quality Commission Raises Concerns Following Alternaleaf Inspection
The UK Care Quality Commission cannabis inspection identified regulatory concerns relevant to clinicians referring patients to licensed producers. These findings emphasize the importance of quality and safety in medical cannabis prescribing. Clinicians…
TGA officials to join cannabis prescribers for annual ANZCCP conference – Cannabiz
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Marijuana tied to weight loss in new Fed study | Cannabis Sciences – Labroots
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
LEVEL Sleep Protab Improved Sleep Quality and Next-Morning Outcomes in Independent …
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Cannabis Rescheduling Arrives, With Limits: What The DOJ’s Final Order Does And Doesn’t Do
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
SYT-510 for Generalized Anxiety Disorder: Phase 2 Trial Dosing Initiated | Psychiatric Times
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…